Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» mdc-IRM
mdc-IRM
Take 2: Teva refiles for approval of long-acting schizophrenia drug months after FDA rejection
Fierce Pharma
Tue, 11/8/22 - 11:06 am
Teva Pharmaceutical
schizophrenia
FDA
mdc-IRM